124
Views
31
CrossRef citations to date
0
Altmetric
Original Article

How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians

, , , , , , & show all
Pages 413-424 | Accepted 27 Jan 2005, Published online: 28 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Fabien Guibal, Lars Iversen, Lluís Puig, Robert Strohal & Paul Williams. (2009) Identifying the biologic closest to the ideal to treat chronic plaque psoriasis in different clinical scenarios: using a pilot multi-attribute decision model as a decision-support aid. Current Medical Research and Opinion 25:12, pages 2835-2843.
Read now
Michel Dib. (2008) Optimizing prophylactic treatment of migraine: Subtypes and patient matching. Therapeutics and Clinical Risk Management 4:5, pages 1061-1078.
Read now
Miguel JA Láinez. (2007) Almotriptan: meeting today’s needs in acute migraine treatment. Expert Review of Neurotherapeutics 7:12, pages 1659-1673.
Read now
Miguel JA Láinez. (2006) Rizatriptan in the treatment of migraine. Neuropsychiatric Disease and Treatment 2:3, pages 247-259.
Read now

Articles from other publishers (26)

Rikki Mangrum, Maya T. Gerstein, Calvin J. HallIIIIII, Dawn C. Buse, Carrie R. Houts, James S. McGinley, Kelly P. McCarrier, Richard B. Lipton & R. J. Wirth. (2023) Priority acute and preventive migraine treatment benefits: Results of the Migraine Clinical Outcome Assessment System (MiCOAS) qualitative study of people living with migraine . Headache: The Journal of Head and Face Pain 63:7, pages 953-964.
Crossref
Adnan I. Qureshi, Kimberley Pfeiffer, Sehar Babar, Wei Huang, Iryna Lobanova, Muhammad F. Ishfaq, Brandi R. French, Farhan Siddiq & Camilo R. Gomez. (2021) Intra‐arterial injection of lidocaine into middle meningeal artery to treat intractable headaches and severe migraine. Journal of Neuroimaging 31:6, pages 1126-1134.
Crossref
Xianpeng Xu, Qingjie Ji & Min Shen. (2021) Patient Preferences and Values in Decision Making for Migraines: A Systematic Literature Review. Pain Research and Management 2021, pages 1-9.
Crossref
Remy R. Coeytaux & John Douglas Mann. 2018. Integrative Medicine. Integrative Medicine 108 119.e3 .
Tiffini Voss, Richard B Lipton, David W Dodick, Nicole Dupre, Joy Yang Ge, Robert Bachman, Christopher Assaid, Sheena K Aurora & David Michelson. (2016) A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine. Cephalalgia 36:9, pages 887-898.
Crossref
Ting-Bin Chen, Yung-Tai Chen, Jong-Ling Fuh, Chao-Hsiun Tang & Shuu-Jiun Wang. (2014) Treatment adherence among new triptan users: a 2-year cohort study in Taiwan. The Journal of Headache and Pain 15:1.
Crossref
Paul Edward Rolan. (2014) Understanding the pharmacology of headache. Current Opinion in Pharmacology 14, pages 30-33.
Crossref
Jerome Goldstein, Timothy Smith, Neil Pugach, James Griesser, Terri Sebree & Mark Pierce. (2014) The Efficacy of Transdermal Sumatriptan Is Too Low for General Use - a Response. Headache: The Journal of Head and Face Pain 54:1, pages 172-174.
Crossref
Stewart J. Tepper, Susy Chen, Faith Reidenbach & Alan M. Rapoport. (2013) Intranasal Zolmitriptan for the Treatment of Acute Migraine. Headache: The Journal of Head and Face Pain 53, pages 62-71.
Crossref
Stephen H. Landy, Stewart J. Tepper, Theodore Wein, Edward Schweizer & Elodie Ramos. (2013) An Open-Label Trial of a Sumatriptan Auto-Injector for Migraine in Patients Currently Treated With Subcutaneous Sumatriptan. Headache: The Journal of Head and Face Pain 53:1, pages 118-125.
Crossref
J. Matías-Guiu, M.T. Caloto & G. Nocea. (2012) Comparison of Expected Outcomes between Patients and Neurologists Using Kanoʼs Methodology in Symptomatic Migraine Treatment. The Patient: Patient-Centered Outcomes Research 5:3, pages 147-162.
Crossref
Jorge Matías-Guiu, M. T. Caloto & G. Nocea. (2012) Comparison of Expected Outcomes between Patients and Neurologists Using Kano’s Methodology in Symptomatic Migraine Treatment. The Patient - Patient-Centered Outcomes Research 5:3, pages 147-162.
Crossref
Cheryl D. Coon, Sheri E. Fehnel, Kimberly H. Davis, M. Chris Runken, M. E. Beach & Roger K. Cady. (2012) The Development of a Survey to Measure Completeness of Response to Migraine Therapy. Headache: The Journal of Head and Face Pain 52:4, pages 550-572.
Crossref
John Douglas Mann & Remy R. Coeytaux. 2012. Integrative Medicine. Integrative Medicine 91 101.e2 .
Stefano Omboni, Lorenzo Pinessi, Lidia Savi, Brigida Fierro, Marco Bartolini, Carlo Lisotto & Giorgio Zanchin. (2011) Suggested randomized, controlled trial for frovatriptan: a reply. The Journal of Headache and Pain 12:6, pages 663-664.
Crossref
Marcelo E. Bigal & Tony W. Ho. (2009) Is there an inherent limit to acute migraine treatment efficacy?. The Journal of Headache and Pain 10:6, pages 393-394.
Crossref
Michel Lanteri-Minet, Fatima Nachit-Ouinekh, Pierre-Louis Druais, François-André Allaert & Abdelkader El Hasnaoui. (2007) Étude d'usage du naratriptan en médecine générale “vigimig”. La Presse Médicale 36:11, pages 1536-1544.
Crossref
R. B. Nett, P. J. Tiseo, M. Almas & C. R. Sikes. (2007) Patient satisfaction with eletriptan in the acute treatment of migraine in primary care. International Journal of Clinical Practice 61:10, pages 1677-1685.
Crossref
A. L. Spatz, J. M. Zakrzewska & E. J. Kay. (2007) Decision analysis of medical and surgical treatments for trigeminal neuralgia: How patient evaluations of benefits and risks affect the utility of treatment decisions. Pain 131:3, pages 302-310.
Crossref
David W. Dodick, Richard B. Lipton, Peter J. Goadsby, Peer Tfelt-Hansen, Michel D. Ferrari, Hans-Christoph Diener, Mary Almas, Kenneth S. Albert & Bruce Parsons. (2007) Predictors of Migraine Headache Recurrence: A Pooled Analysis From the Eletriptan Database. Headache: The Journal of Head and Face Pain 0:0, pages 070629211050002-???.
Crossref
Richard Hargreaves. (2007) New Migraine and Pain Research. Headache: The Journal of Head and Face Pain 47:s1, pages S26-S43.
Crossref
PJ Goadsby, DW Dodick, M Almas, H-C Diener, P Tfelt-Hansen, RB Lipton & B Parsons. (2016) Treatment-Emergent CNS Symptoms Following Triptan Therapy are Part of The Attack. Cephalalgia 27:3, pages 254-262.
Crossref
Fernando Iglesias Díez, Andreas Straube & Giorgio Zanchin. (2007) Patient preference in migraine therapy. Journal of Neurology 254:2, pages 242-249.
Crossref
J. Douglas Mann & Remy R. Coeytaux. 2007. Integrative Medicine. Integrative Medicine 143 156 .
John Edmeads. (2006) Understanding the Needs of Migraine Patients. Drugs 66:Suppl 3, pages 1???8.
Crossref
Peter J. Goadsby & Roger Yates. (2006) Zolmitriptan Intranasal: A Review of the Pharmacokinetics and Clinical Efficacy. Headache: The Journal of Head and Face Pain 46:1, pages 138-149.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.